Noom Med

Noom Med is the medical weight loss arm of Noom, the company known for its psychology-based behaviour change approach to weight management. Unlike platforms that focus solely on medication access, Noom Med layers GLP-1 prescriptions on top of a comprehensive digital programme including daily psychology-based lessons, personalised coaching, protein tracking, muscle preservation workouts, and a structured tapering protocol for life after medication. In 2026, Noom Med offers five distinct programme tiers: the Microdose GLP-1Rx programme from $79/month for those wanting a lower-dose entry point with fewer side effects; the standard GLP-1Rx programme from $129/month with full titration; the Proactive Health Microdose programme at $149/month including biomarker monitoring; and telehealth support for branded medications from $69/month for insurance users. Compounded semaglutide is sourced from USP-compliant 503B compounding pharmacies with third-party testing certificates available. The platform reports users lose 48% more weight on Noom Med compared to medication alone, based on internal retrospective data. FSA and HSA eligible.